Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
Christopher M. StarrDirector | Monopar TherapeuticsMNPR10b5-1 plan | 16,800 sh | $1,338,456 | 10/01 | Filed 10/01 |
Chandler RobinsonDirector, Officer | Monopar TherapeuticsMNPR10b5-1 plan | 29,056 sh | $2,597,025.28 | 09/24 | Filed 09/24 |
Patrice RiouxActing Chief Medical Officer | Monopar TherapeuticsMNPR10b5-1 plan | 1 sh | $110.82 | 08/26 | Filed 08/26 |
Kim R. TsuchimotoDirector | Monopar TherapeuticsMNPR10b5-1 plan | 8,180 sh | $906,507.6 | 08/26 | Filed 08/26 |
Raymond AndersonDirector | Monopar TherapeuticsMNPR10b5-1 plan | 6,284 sh | $699,786.24 | 08/25 | Filed 08/25 |
Monopar TherapeuticsMNPRAmendment | 5,000 sh | $476,967 | 07/08 | Filed 07/10 | |
Arthur J. KlausnerEmployer | Monopar TherapeuticsMNPR | 5,000 sh | $485,250 | 07/07 | Filed 07/07 |
Arthur J. KlausnerBoard Member | Monopar TherapeuticsMNPR | 5,121 sh | $343,903.47 | 25/12/18 | Filed 25/12/19 |
Christopher M. StarrDirector | Monopar TherapeuticsMNPR | 16,800 sh | $672,000 | 25/07/14 | Filed 25/07/14 |
Kim R. TsuchimotoDirector | Monopar TherapeuticsMNPR | 8,904 sh | $356,160 | 25/07/14 | Filed 25/07/14 |
Chandler RobinsonOfficer, Director | Monopar TherapeuticsMNPR | 16,800 sh | $672,000 | 25/07/14 | Filed 25/07/14 |
Tactic Pharma Llc10% Stockholder | Monopar TherapeuticsMNPR | 33,334 sh | $1,166,806 | 25/04/02 | Filed 25/04/02 |
